EXACT Sciences Corporation (EXAS) — Cash Flow Reinvestment Rate
EXACT Sciences Corporation (EXAS) has a Cash Flow Reinvestment Rate of 1.51x as of December 2025, reinvesting $228.60 Million (capex $31.24 Million plus investments $197.36 Million) from operating cash flow of $151.69 Million. See EXACT Sciences Corporation free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
EXACT Sciences Corporation Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for EXACT Sciences Corporation across 4 annual periods. For the full cash flow conversion analysis, see EXACT Sciences Corporation (EXAS) cash flow conversion.
Annual Cash Flow Reinvestment Rate for EXACT Sciences Corporation (2020–2025)
Year-by-year capital reinvestment analysis for EXACT Sciences Corporation. See financial agility of EXACT Sciences Corporation to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.04x | $511.17 Million | $491.44 Million | $134.66 Million | ▼ -62.1% |
| 2024 | 2.75x | $578.14 Million | $210.54 Million | $135.99 Million | ▲ +146.6% |
| 2023 | 1.11x | $173.87 Million | $156.12 Million | $124.19 Million | ▼ -46.4% |
| 2020 | 2.08x | $283.58 Million | $136.48 Million | $64.35 Million | — |